Orchard Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Feb 5 14:43 ET
Orchard Therapeutics | S-8 POS: S-8 POS
Jan 24 16:45 ET
Orchard Therapeutics | S-8 POS: S-8 POS
Jan 24 16:45 ET
Orchard Therapeutics | S-8 POS: S-8 POS
Jan 24 16:40 ET
Orchard Therapeutics | S-8 POS: S-8 POS
Jan 24 16:40 ET
Orchard Therapeutics | S-8 POS: S-8 POS
Jan 24 16:36 ET
Orchard Therapeutics | S-8 POS: S-8 POS
Jan 24 16:36 ET
Orchard Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Jan 24 16:31 ET
Orchard Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Jan 24 16:30 ET
Orchard Therapeutics | 8-K: Current report
Jan 24 16:21 ET
Orchard Therapeutics | 8-K: Current report
Jan 22 00:00 ET
Orchard Therapeutics | 8-K: Current report
Dec 19, 2023 16:49 ET
Orchard Therapeutics | DEFA14A: Others
Dec 8, 2023 16:39 ET
Orchard Therapeutics | 8-K: Current report
Dec 8, 2023 16:37 ET
Orchard Therapeutics | DEFA14A: Others
Nov 30, 2023 16:13 ET
Orchard Therapeutics | 8-K: Current report
Nov 30, 2023 16:06 ET
Orchard Therapeutics | DEFA14A: Others
Nov 21, 2023 07:53 ET
Orchard Therapeutics | 8-K: Current report
Nov 21, 2023 07:51 ET
Orchard Therapeutics | DEFM14A: Definitive proxy statement relating to merger or acquisition
Nov 16, 2023 16:45 ET
Orchard Therapeutics | 8-K: Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
Nov 13, 2023 07:05 ET
No Data
No Data